{
"@context": "https://schema.org",
"@type": "Article",
"headline": "No Surprises Here! Shareholder Derivative Lawsuit Challenging Provider Use of No Surprises Act IDR Process Portends New Corporate Governance Risks",
"url": "https://www.lexblog.com/2025/10/06/no-surprises-here-shareholder-derivative-lawsuit-challenging-provider-use-of-no-surprises-act-idr-process-portends-new-corporate-governance-risks/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-WFDZ1MPC",
"url": "https://www.lexblog.com/lib/WFDZ1MPC/"
},
"datePublished": "2025-10-06T11:50:02-04:00",
"dateModified": "2025-10-06T08:50:32-04:00",
"author": {
"@type": "Person",
"name": "Vinay Kohli, D. Austin Rettew"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Proskauer Rose LLP"
},
"organizationScope": "at-publication",
"about": "Corporate Governance and Compliance · Health Care and Life Sciences",
"sourceUrl": "https://www.healthcarelawbrief.com/?p=2777",
"sourceStability": "may-move"
}